Guinea-Bissau vs Spain: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Guinea-Bissau
90.0%
in 2025
Spain
89.0%
in 2025
Guinea-Bissau rank
68th
Spain rank
70th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Guinea-Bissau
- Spain
How they compare
Guinea-Bissau currently reports 90.0% against 89.0% in Spain, a difference of 1.0%.
The two have swapped places 3 times across 18 shared years of data; in 2008 it was Spain ahead.
Guinea-Bissau ranks 68th and Spain ranks 70th of 192 countries.
Across the 3 decades both report, Guinea-Bissau averaged higher in 1 and Spain in 1.
Head to head by decade
| Decade | Guinea-Bissau | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 34.1% | 27.8% | 6.3% | Guinea-Bissau |
| 2020s | 85.5% | 92.5% | 7.0% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Guinea-Bissau or Spain?
- Guinea-Bissau, at 90.0% against 89.0% in Spain as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Guinea-Bissau and Spain?
- 1.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Spain?
- 18 years are reported by both, from 2008 to 2025.
- How do Guinea-Bissau and Spain rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Guinea-Bissau ranks 68th and Spain ranks 70th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.